课题基金 / 基金详情

Clinical feasibility of individually optimal chemotherapy based on the molecular targets in brain tumors

Clinical feasibility of individually optimal chemotherapy based on the molecular targets in brain tumors
基于脑肿瘤分子靶点的个体化最佳化疗的临床可行性
批准号:
14370443
负责人:
MINEURA Katsuyoshi
金额:
$6.91万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

MINEURA Katsuyoshi的其他基金

相似基金

相关文献

中文摘要
翻译
免疫组化研究可能有助于更好地了解O^6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)活性的位置和分布。脑肿瘤在组织结构和生物学特性上具有异质性。MGMT活性在脑肿瘤之间,甚至在个体肿瘤组织内变化很大。MGMT活性,特别是从活检标本判断时,可能容易低估活性的程度。最好的确认需要大量的肿瘤组织,其中包含肿瘤最活跃的部分。基因改变的测定是有用的,1 p和/或19 q的缺失是药物敏感性的标志。少突胶质细胞瘤合并1 p和19 q缺失显著延长生存期。因此,化疗方案的选择和应用应根据个体肿瘤的生物学和分子特征。 ...更多信息 肿瘤组织的切除量通常是有限的。由于正电子发射断层扫描(PET)可以成像整个肿瘤,因此它克服了这些问题与组织学评价单独。在本研究中,我们在治疗前获得了胶质瘤中硼衍生物的体内证据。13 <18>F-13 <10>B-氟硼苯丙氨酸(FBPA)被认为是通过血脑屏障和在肿瘤细胞中的氨基酸转运过程的指示剂。FBPA-PET方法是准确的测量FBPA纳入胶质瘤,即使是组织学诊断是不够的,因为少量的组织活检。FBPA-PET在预测预后和确定胶质瘤对硼中子俘获治疗是否敏感方面具有实用性和临床价值,积累对基因改变和体内关键生物学特性的认识将建立脑肿瘤的个体化最佳治疗方法,包括化疗。少
英文摘要
Immunohistochemical studies might provide superiority in better understanding the location and distribution of O^6-methylguanine-DNA methyltransferase (MGMT) activity. Brain tumors are heterogeneous in histological structure and biological properties. MGMT activity varies widely among brain tumors and even within individual tumor tissue. MGMT activity, especially when judged from biopsied specimens, may easily underestimate the degree of the activity. Best confirmation requires a large amount of tumor tissue containing the most active parts of a tumor.Determinations of genetic alternation are useful and loss of 1p and/or 19q is a landmark of drug sensitivity. Oligodendrogliomas having combined loss of 1p and 19q significantly prolong survival. Thus, chemotherapy regimen should be selected and applied on according to individual tumors based on biological and molecular characteristics.There is a critical disadvantage in obtaining biological information on the entire brain tumors because … More the resected amounts of tumor tissue are often limited. Since positron emission tomography (PET) can image the entire tumor, it therefore overcomes such problems with histologic evaluation alone. In the present study, we obtained in vivo evidence of boron-derivatives in gliomas prior to treatment. ^<18>F-^<10>B-Fluoroboronophenylalanine (FBPA) is accepted as an indicator of the amino acid transport process through blood-brain barrier and in the tumor cells. FBPA-PET method was accurate for the measurements of FBPA incorporation in gliomas ; even the histologic diagnosis was insufficient because of the small amounts of tissue available from biopsy. FBPA-PET is practical and clinically useful for predicting prognosis and for determining whether tumors will be sensitive or resistant boron neutron capture therapy in gliomas.Accumulation of knowledge of genetic alternations and in vivo crucial biological properties will establish the individual optimum treatments including chemotherapy in brain tumors. Less
期刊论文(42)
专著(0)
科研奖励(0)
会议论文
Yamada K, Kizu O, Mori S, Ito H, Nakamura H, Yuen S, Kubota T, Tanaka O, Akada W, Sasajima H, Mineura K, Nishimura T: "Brain fiber tracking with clinically feasible diffusion-tensor MR imaging. Initial experience."Radiology. 227. 295-301 (2003)
Yamada K、Kizu O、Mori S、Ito H、Nakamura H、Yuen S、Kubota T、Tanaka O、Akada W、Sasajima H、Mineura K、Nishimura T:“利用临床上可行的扩散张量 MR 成像进行脑纤维追踪。初始
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Murakami M et al.: "A consistent region of deletion on 1p36 in meningiomas. Identification and relation to malignant progression"Cancer Genet Cytogen. (in press). (2003)
Murakami M 等人:“脑膜瘤中 1p36 上的一致缺失区域。鉴定及其与恶性进展的关系”Cancer Genet Cytogen。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hashimoto N et al.: "Diagnostic molecular genetics and its application to clinical decision in brain tumors"International Congress Series. 1247. 221-229 (2002)
Hashimoto N 等人:“诊断分子遗传学及其在脑肿瘤临床决策中的应用”国际大会系列。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sasajima H, Mineura K, Hashimoto N: "Surgery of deep-seated brain tumors."International Congress Series 1247 (Watanabe K ed) (Developments in Neuroscience) (Elsevier Science BV, Amsterdam). 173-183 (2002)
Sasajima H、Mineura K、Hashimoto N:“深部脑肿瘤手术”。国际大会系列 1247(Watanabe K ed)(神经科学发展)(Elsevier Science BV,阿姆斯特丹)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 28 条
    Individually optimum therapy based on less invasive bio-imaging in brain yumors
    • 批准号:
      18390401
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.56万
    • 财政年份:
      2006
    • 负责人:
      MINEURA Katsuyoshi
    • 依托单位:
    Logistic strategy for molecule-targeting therapy in brain tumors
    • 批准号:
      16390416
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.02万
    • 财政年份:
      2004
    • 负责人:
      MINEURA Katsuyoshi
    • 依托单位:
    MOLECULAR-BASIS AUGMENTED CHEMOTHERAPY AND CLINICAL APPLICATION IN BRAIN TUMORS
    • 批准号:
      12470296
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.64万
    • 财政年份:
      2000
    • 负责人:
      MINEURA Katsuyoshi
    • 依托单位:
    Strategy for Selective Brain Tumor Chemotherapy Involved in O^6-Methylguanine-DNA Methyltransferase
    • 批准号:
      07457304
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.03万
    • 财政年份:
      1995
    • 负责人:
      MINEURA Katsuyoshi
    • 依托单位:
    国内基金
    海外基金
    O6-methyl-dGTP抑制胶质母细胞瘤的作用及分子机制研究
    • 批准号:
      82304565
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30.00万元
    • 批准年份:
      2023
    • 负责人:
      李瑾
    • 依托单位:
    基于Notch-1介导miR-200家族调控上皮间质转化对绒癌耐药机制的研究
    • 批准号:
      81972428
    • 项目类别:
      面上项目
    • 资助金额:
      55.0万元
    • 批准年份:
      2019
    • 负责人:
      安瑞芳
    • 依托单位:
    地塞米松诱导的人卵巢癌对化疗药物耐受及其机制的研究
    维生素B3促进化疗导致粒细胞减少症的中性粒细胞生成功能及作用机制研究
    • 批准号:
      81060045
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      26.0万元
    • 批准年份:
      2010
    • 负责人:
      蓝丹
    • 依托单位: